On January 22, 2021, the Montreal Heart Institute announced positive results from COLCORONA trial.The COLCORONA study manuscript is now available in the public domain.
Colcorona is a home-based clinical trial that determines whether short-term treatment with an existing medication reduces the risk of mortality and lung complications related to COVID-19.It is a randomized, placebo-controlled study. It is double-blind - which means neither doctor nor patient will know whether you are taking the trial medication or a placebo.
You must have been diagnosed with and currently have COVID-19
You must be 40 years old or over
Trial lasts 30 days from home
Daily intake of study medication or placebo
You must not be in hospital due to COVID-19
You must not be pregnant or breastfeeding
